Brendan Rasor

Comparison of fixed dose reduced-intensity conditioning with fludarabine and busulfan to PK-guided busulfan AUC (FluBu4K) in hematopoietic stem cell transplant for AML/MDS

Leukemia & lymphoma/Leukemia and lymphoma · 2021 · First of 16 authors · 7 citations

Characteristics of hospitalizations among patients receiving immune checkpoint inhibitors at a community teaching hospital

Journal of Oncology Pharmacy Practice · 2020 · First of 3 authors · 7 citations